C. Greineder

发表

Dynamics of intrapulmonary bacterial growth in a murine model of repeated microaspiration.

D. Bortz, J. Younger, I. Ben-David, 2005, American journal of respiratory cell and molecular biology.

Collaborative Enhancement of Antibody Binding to Distinct PECAM-1 Epitopes Modulates Endothelial Targeting

V. Muzykantov, C. Greineder, A. Chacko, 2012, PloS one.

Reduction of nanoparticle avidity enhances the selectivity of vascular targeting and PET detection of pulmonary inflammation.

V. Muzykantov, R. Radhakrishnan, C. Greineder, 2013, ACS nano.

Ferritin Nanocages with Biologically Orthogonal Conjugation for Vascular Targeting and Imaging.

C. Villa, V. Muzykantov, C. Greineder, 2018, Bioconjugate chemistry.

Bivalent engagement of endothelial surface antigens is critical to prolonged surface targeting and protein delivery in vivo

C. Villa, V. Muzykantov, C. Greineder, 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Site-Specific Modification of Single-Chain Antibody Fragments for Bioconjugation and Vascular Immunotargeting.

Colin F Greineder, Vladimir R Muzykantov, Andrew Tsourkas, 2017, Bioconjugate chemistry.

Vascular endothelial effects of collaborative binding to platelet/endothelial cell adhesion molecule-1 (PECAM-1)

C. Villa, V. Muzykantov, C. Greineder, 2018, Scientific Reports.

Molecular engineering of high affinity single-chain antibody fragment for endothelial targeting of proteins and nanocarriers in rodents and humans.

V. Muzykantov, C. Greineder, M. Poncz, 2016, Journal of controlled release : official journal of the Controlled Release Society.

Vascular Accessibility of Endothelial Targeted Ferritin Nanoparticles.

V. Muzykantov, C. Greineder, I. Dmochowski, 2016, Bioconjugate chemistry.

Augmenting the protein C pathway with endothelial targeted biotherapeutics: Strategies to promote partnering of TM and EPCR

C. Greineder, 2014 .

Antioxidant protection by PECAM-targeted delivery of a novel NADPH-oxidase inhibitor to the endothelium in vitro and in vivo.

C. Dodia, V. Muzykantov, A. Fisher, 2012, Journal of controlled release : official journal of the Controlled Release Society.

Advanced drug delivery systems for antithrombotic agents.

V. Muzykantov, C. Greineder, D. Cines, 2013, Blood.

Site-Specific Modification of Single-Chain Affinity Ligands for Fluorescence Labeling, Radiolabeling, and Bioconjugation.

C. Greineder, Boya Zhang, Sachith M Vidanapathirana, 2021, Methods in molecular biology.

The new frontiers of the targeted interventions in the pulmonary vasculature: precision and safety (2017 Grover Conference Series)

V. Muzykantov, C. Greineder, H. Parhiz, 2017, Pulmonary circulation.

ICAM-1-targeted thrombomodulin mitigates tissue factor-driven inflammatory thrombosis in a human endothelialized microfluidic model.

C. Villa, C. Esmon, V. Muzykantov, 2017, Blood advances.

Endothelial nanomedicine for the treatment of pulmonary disease

V. Muzykantov, C. Greineder, V. Shuvaev, 2015, Expert opinion on drug delivery.

Endothelial targeting of nanocarriers loaded with antioxidant enzymes for protection against vascular oxidative stress and inflammation.

Robert J Levy, Colin F Greineder, Vladimir R Muzykantov, 2014, Biomaterials.

Combining vascular targeting and the local first pass provides 100‐fold higher uptake of ICAM‐1‐targeted vs untargeted nanocarriers in the inflamed brain

C. Villa, V. Muzykantov, C. Greineder, 2019, Journal of controlled release : official journal of the Controlled Release Society.

Vascular Immunotargeting to Endothelial Determinant ICAM-1 Enables Optimal Partnering of Recombinant scFv-Thrombomodulin Fusion with Endogenous Cofactor

C. Esmon, V. Muzykantov, Jingyan Han, 2013, PloS one.

Endothelial targeting of liposomes encapsulating SOD/catalase mimetic EUK-134 alleviates acute pulmonary inflammation.

V. Muzykantov, C. Greineder, E. Hood, 2014, Journal of controlled release : official journal of the Controlled Release Society.

A hybridoma-derived monoclonal antibody with high homology to the aberrant myeloma light chain

C. Greineder, H. Remmer, P. Tessier, 2021, bioRxiv.

Immunolocalization of anion transporter Slc26a7 in mouse kidney.

C. Greineder, P. Aronson, D. Biemesderfer, 2006, American journal of physiology. Renal physiology.

Collaborative Enhancement of Endothelial Targeting of Nanocarriers by Modulating Platelet-Endothelial Cell Adhesion Molecule-1/CD31 Epitope Engagement.

V. Muzykantov, Jingyan Han, C. Greineder, 2015, ACS nano.

Mechanism of Collaborative Enhancement of Binding of Paired Antibodies to Distinct Epitopes of Platelet Endothelial Cell Adhesion Molecule-1

C. Villa, V. Muzykantov, C. Greineder, 2017, PloS one.

Flexible Nanoparticles Reach Sterically Obscured Endothelial Targets Inaccessible to Rigid Nanoparticles

V. Muzykantov, M. Grady, C. Greineder, 2018, Advanced materials.

Human intestinal lamina propria and intraepithelial lymphocytes express receptors specific for chemokines induced by inflammation

E. Ebert, C. Greineder, A. Roberts, 2000, European journal of immunology.

Targeted In Vivo Loading of Red Blood Cells Markedly Prolongs Nanocarrier Circulation.

C. Villa, V. Muzykantov, C. Greineder, 2022, Bioconjugate chemistry.

Heart Failure Associated with Sunitinib: Lessons Learned from Animal Models

C. Greineder, B. Ky, S. Kohnstamm, 2011, Current hypertension reports.

Platelet Endothelial Cell Adhesion Molecule Targeted Oxidant-Resistant Mutant Thrombomodulin Fusion Protein with Enhanced Potency In Vitro and In Vivo

C. Esmon, V. Muzykantov, C. Greineder, 2013, The Journal of Pharmacology and Experimental Therapeutics.

Molecularly Engineered Nanobodies for Tunable Pharmacokinetics and Drug Delivery.

C. Villa, V. Muzykantov, C. Greineder, 2020, Bioconjugate chemistry.

Early Convalescent Plasma for High-Risk Outpatients with Covid-19

D. Beiser, K. Schulman, R. Silbergleit, 2021, The New England journal of medicine.

Targeting thrombomodulin to circulating red blood cells augments its protective effects in models of endotoxemia and ischemia‐reperfusion injury

D. Atochin, C. Villa, C. Esmon, 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Supramolecular Arrangement of Protein in Nanoparticle Structures Predicts Nanoparticle Tropism for Neutrophils in Acute Lung Inflammation

V. Rotello, J. Lahann, S. Mitragotri, 2021, Nature Nanotechnology.

Anchoring IgG-degrading enzymes to the surface of platelets selectively neutralizes antiplatelet antibodies

C. Greineder, B. Curtis, J. Palumbo, 2022, Blood advances.

Mechanisms that determine nanocarrier targeting to healthy versus inflamed lung regions.

C. Villa, V. Muzykantov, R. Radhakrishnan, 2017, Nanomedicine : nanotechnology, biology, and medicine.

Biocompatible coupling of therapeutic fusion proteins to human erythrocytes.

C. Villa, V. Muzykantov, C. Greineder, 2018, Blood advances.

Dual targeting of therapeutics to endothelial cells: collaborative enhancement of delivery and effect

C. Esmon, V. Muzykantov, C. Greineder, 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Targeting therapeutics to endothelium: are we there yet?

V. Muzykantov, C. Greineder, V. Shuvaev, 2018, Drug Delivery and Translational Research.

Supramolecular Organization Predicts Protein Nanoparticle Delivery to Neutrophils for Acute Lung Inflammation Diagnosis and Treatment

V. Rotello, J. Lahann, S. Mitragotri, 2020, bioRxiv.

Effect of pulmonary embolism response team on advanced therapies administered: The University of Michigan experience.

C. Greineder, Nelish Ardeshna, G. Barnes, 2022, Thrombosis research.

Selective targeting of nanomedicine to inflamed cerebral vasculature to enhance the blood–brain barrier

C. Villa, V. Muzykantov, C. Greineder, 2020, Proceedings of the National Academy of Sciences.

Vascular endothelial effects of collaborative binding to platelet/endothelial cell adhesion molecule-1 (PECAM-1)

C. Villa, V. Muzykantov, C. Greineder, 2018, Scientific Reports.

Targeting to Endothelial Cells Augments the Protective Effect of Novel Dual Bioactive Antioxidant/Anti-Inflammatory Nanoparticles

I. Alferiev, V. Muzykantov, C. Greineder, 2014, Molecular pharmaceutics.

Bispecific antibody shuttles targeting CD98hc mediate efficient and long-lived brain delivery of IgGs

C. Greineder, Peter M. Tessier, Boya Zhang, 2023, bioRxiv.

Adverse Clinical Outcomes Among Patients With Acute Low-risk Pulmonary Embolism and Concerning Computed Tomography Imaging Findings

C. Greineder, K. Kocher, J. Cranford, 2023, JAMA network open.

Vascular Targeting of Radiolabeled Liposomes with Bio-Orthogonally Conjugated Ligands: Single Chain Fragments Provide Higher Specificity than Antibodies.

C. Villa, V. Muzykantov, C. Greineder, 2018, Bioconjugate chemistry.

Targeted nanocarriers coopting pulmonary leukocytes for drug delivery to the injured brain

D. Weissman, S. Kasner, C. Villa, 2022, bioRxiv.

A Bioreactor for 3D In Vitro Modeling of the Mechanical Stimulation of Osteocytes

J. Lahann, C. Greineder, G. Mehta, 2022, Frontiers in Bioengineering and Biotechnology.

Systems approaches to design of targeted therapeutic delivery

Jacob W Myerson, Jacob S Brenner, Colin F Greineder, 2015, Wiley interdisciplinary reviews. Systems biology and medicine.

Molecular engineering of antibodies for site-specific covalent conjugation using CRISPR/Cas9

C. Villa, V. Muzykantov, C. Greineder, 2018, Scientific Reports.

Targeted Nanocarriers Co-Opting Pulmonary Intravascular Leukocytes for Drug Delivery to the Injured Brain.

D. Weissman, S. Kasner, C. Villa, 2023, ACS nano.

In vitro and in silico analysis of annexin V binding to lymphocytes as a biomarker in emergency department sepsis studies.

J. Younger, C. Greineder, P. Nelson, 2007, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

Shoulder Pseudodislocation Associated with Calcific Tendinitis/Bursitis and Diagnosed by Point of Care Ultrasound.

C. Greineder, N. Theyyunni, K. Grace, 2020, Journal of Emergency Medicine.

Molecular engineering of antibodies for site-specific covalent conjugation using CRISPR/Cas9

C. Villa, V. Muzykantov, C. Greineder, 2018, Scientific Reports.

Targeting therapeutics to endothelium: are we there yet?

V. Muzykantov, C. Greineder, V. Shuvaev, 2017, Drug Delivery and Translational Research.

Antioxidant protection by PECAM-targeted delivery of a novel NADPH-oxidase inhibitor to the endothelium in vitro and in vivo.

C. Dodia, V. Muzykantov, A. Fisher, 2012, Journal of controlled release : official journal of the Controlled Release Society.